Targeting Mutated Plus Germline Epitopes Confers Pre-Clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4+ and CD8+ T-Cell Epitopes

Frontiers in Oncology
Cancer ResearchOncology
2018English

Safety and Efficacy Profile of Nano-Formulated, Lower Dose Non-Steroidal Anti-Inflammatory Drugs

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2012English

A Recurrent Germline PAX5 Mutation Confers Susceptibility to Pre-B Cell Acute Lymphoblastic Leukemia

Nature Genetics
Genetics
2013English

An in Silico Chimeric Vaccine Targeting Breast Cancer Containing Inherent Adjuvant

Iranian Journal of Cancer Prevention
2015English

Efficacy of an Anti-Cancer Strategy Targeting SET in Canine Osteosarcoma

Journal of Veterinary Medical Science
Veterinary
2019English

Prior Exposure to an Attenuated Listeria Vaccine Does Not Reduce Immunogenicity: Pre-Clinical Assessment of the Efficacy of a Listeria Vaccine in the Induction of Immune Responses Against HIV

Journal of Immune Based Therapies and Vaccines
2011English

Bringing Prostate Cancer Germline Genetics Into Clinical Practice

Journal of Urology
Urology
2019English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer

World Journal of Vaccines
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy